MSD Contact Information Legal Terms MSD Jobs
MESO SCALE DISCOVERY
MESO SCALE DISCOVERY
Catalog
MULTI-ARRAY Detection Technology
Products
Literature & Publications
Applications Literature
Brochures
Customer Presentations
MSD Assay Product Inserts
Technical & Application Notes
MSD Publication References
Our Company
Purchase MSD Assays
Shows & Events We Attend
 



Publications

Sarcoidosis and Tuberculosis Cytokine Profiles: Indistinguishable in Bronchoalveolar Lavage but Different in Blood.

Thillai M, Eberhardt C, Lewin AM, Potiphar L, Hingley-Wilson S, Sridhar S, Macintyre J, Kon OM, Wickremasinghe M, Wells A, Weeks ME, Mitchell D, Lalvani A.

Journal PLoS One Year 2012
Species Human Volume 7 (7)
IFN-γ, IL-1β, IL-10, IL-12 p70, IL-13, IL-2, IL-4, IL-5, IL-8, TNF-α Page # 38083
Matrix Tested Bronchoalveolar lavage (BAL) fluid, serum Cytokines & Chemokines

Abstract

Background: The clinical, radiological and pathological similarities between sarcoidosis and tuberculosis can make disease differentiation challenging. A complicating factor is that some cases of sarcoidosis may be initiated by mycobacteria. We hypothesised that immunological profiling might provide insight into a possible relationship between the diseases or allow us to distinguish between them.

Methods: We analysed bronchoalveolar lavage (BAL) fluid in sarcoidosis (n = 18), tuberculosis (n = 12) and healthy volunteers (n = 16). We further investigated serum samples in the same groups; sarcoidosis (n = 40), tuberculosis (n = 15) and healthy volunteers (n = 40). A cross-sectional analysis of multiple cytokine profiles was performed and data used to discriminate between samples.

Results: We found that BAL profiles were indistinguishable between both diseases and significantly different from healthy volunteers. In sera, tuberculosis patients had significantly lower levels of the Th2 cytokine interleukin-4 (IL-4) than those with sarcoidosis (p = 0.004). Additional serum differences allowed us to create a linear regression model for disease differentiation (within-sample accuracy 91%, cross-validation accuracy 73%).

Conclusions: These data warrant replication in independent cohorts to further develop and validate a serum cytokine signature that may be able to distinguish sarcoidosis from tuberculosis. Systemic Th2 cytokine differences between sarcoidosis and tuberculosis may also underly different disease outcomes to similar respiratory stimuli.


Related Products
Human TH1/TH2 10-Plex Ultra-Sensitive Kit
Human Chemokine 7-Plex Ultra-Sensitive Kit
Human Chemokine 9-Plex Base Kit
Human Chemokine 9-Plex Tissue Culture Kit
Human Chemokine 9-Plex Ultra-Sensitive Kit
Human Demonstration 10-Plex Base Kit
Human Demonstration 10-Plex Tissue Culture Kit
Human Demonstration 4-Plex Base Kit
Human Demonstration 4-Plex Tissue Culture Kit
Human Demonstration 7-Plex Base Kit

view more

Suggest a Reference


Speak with a Scientist



CAREERS     |     CONTACT US     |     LEGAL     |     PRIVACY
Feedback Form
Feedback Analytics